Match each complex neurological or paraneoplastic clinical presentation with the most specific and appropriate targeted diagnostic laboratory test.
- An otherwise healthy 62-year-old female patient is evaluated for a three-month history of rapidly progressive memory loss, exaggerated startle response (myoclonus), and gait instability. Electroencephalogram reveals 1-Hz generalized periodic sharp wave complexes.Cerebrospinal fluid real-time quaking-induced conversion (RT-QuIC) assay
- Two months following resection of an ovarian teratoma, a 26-year-old female patient develops acute severe psychiatric disturbances, prominent orofacial dyskinesias, and subsequent autonomic instability requiring intensive care.Cerebrospinal fluid analysis for anti-GluN1 (NMDA) receptor IgG antibodies
- A 68-year-old male with a 40-pack-year tobacco use history exhibits subacute onset of severe dysarthria and appendicular ataxia. Initial chest radiography raises high suspicion for a central lung malignancy.Serum panel for anti-Hu (ANNA-1), anti-Yo (PCA-1), and anti-Ri (ANNA-2) antibodies
- Following a documented episode of bacterial gastroenteritis, a 45-year-old male develops acute bilateral ophthalmoplegia, significant gait ataxia, and diffuse areflexia without prominent limb weakness.Serum testing for anti-GQ1b ganglioside antibodies
Cevap
The correct pairings match the underlying syndrome to its specific diagnostic assay: Creutzfeldt-Jakob disease pairs with the RT-QuIC assay; Anti-NMDA receptor encephalitis pairs with anti-GluN1 receptor antibodies; Paraneoplastic cerebellar degeneration pairs with the anti-Hu/Yo/Ri panel; and Miller Fisher syndrome pairs with anti-GQ1b ganglioside testing.
Each clinical vignette presents a highly specific neurological autoimmune or rapidly progressive degenerative syndrome that corresponds uniquely to a specialized diagnostic laboratory test. Properly ordering these tests prevents diagnostic delay and premature closure in rare but critical conditions.
Adım Adım Çözüm
Anahtar Kavram
Targeted laboratory evaluation of rapidly progressive neurological and paraneoplastic syndromes based on highly specific clinical phenotypes.
Tahmini Süre:2m 0s